Researchers at UAQ are reporting promising developments in their efforts to produce a pioneering vaccine against screwworm in cattle.
Correct administration technique is critical to getting the full benefit of any injectable mineral supplementation program, ...
New LEQEMBI Companion TM program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an ...
Beef prices are at a record high in the wake of a drought that left cattle inventory at the lowest level in 70 years amid strong demand, resulting in price increases for steak and ground beef. The ...
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...
The body’s defenses may be mildly lowered for about 1 to 4 weeks after a single steroid shot into a joint or near your spine. In some people, particularly with higher doses, this effect may last up to ...
I believe that Merck (NYSE:MRK) is a good long-term pharmaceutical company to own and with that being said, it is because of several excellent moves it has made in the last few years. The first major ...
The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...
Mexico activated emergency controls Monday after detecting a new case of New World screwworm in cattle in the northern border state of Nuevo Leon, the closest case to the U.S. border since the ...
Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...
Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster administration and broader access to immunotherapy. The FDA approved Merck’s ...